Brett Sandercock Resmed Inc (RSMDF) insider trading activity

Brett Sandercock is Chief Financial Officer of RESMED INC. Currently has a direct ownership of 86,745 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Oct 01, 2025, when has been sold 3,000 shares (ResMed Common Stock) at a price of $274.36 per share, resulting in proceeds of $823,080. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 86.7K

2.92% 3M change

9.46% 12M change

Total Value Held $0

Brett Sandercock Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 01 2025	SELL Open market or private sale	$823,080 $274.36 p/Share	3,000 Reduced 3.34%	86,745 ResMed Common Stock
Oct 01 2025	BUY Exercise of conversion of derivative security	$203,280 $101.64 p/Share	2,000 Added 2.18%	89,745 ResMed Common Stock
Sep 02 2025	SELL Open market or private sale	$812,310 $270.77 p/Share	3,000 Reduced 3.31%	87,745 ResMed Common Stock
Sep 02 2025	BUY Exercise of conversion of derivative security	$203,280 $101.64 p/Share	2,000 Added 2.16%	90,745 ResMed Common Stock
Aug 15 2025	BUY Grant, award, or other acquisition	-	5,462 Added 5.8%	88,745 ResMed Common Stock
Aug 01 2025	SELL Open market or private sale	$845,699 $281.9 p/Share	3,000 Reduced 3.48%	83,283 ResMed Common Stock
Aug 01 2025	BUY Exercise of conversion of derivative security	$203,280 $101.64 p/Share	2,000 Added 2.27%	86,283 ResMed Common Stock
Jul 01 2025	SELL Open market or private sale	$997,892 $256.99 p/Share	3,883 Reduced 4.4%	84,283 ResMed Common Stock
Jul 01 2025	BUY Exercise of conversion of derivative security	$293,028 $101.64 p/Share	2,883 Added 3.17%	88,166 ResMed Common Stock
Jun 02 2025	SELL Open market or private sale	$243,780 $243.78 p/Share	1,000 Reduced 1.16%	85,283 ResMed Common Stock
May 22 2025	SELL Open market or private sale	$891,285 $244.59 p/Share	3,644 Reduced 4.05%	86,283 ResMed Common Stock
Apr 08 2025	SELL Open market or private sale	$215,580 $215.58 p/Share	1,000 Reduced 1.1%	89,864 ResMed Common Stock
Mar 10 2025	SELL Open market or private sale	$230,360 $230.36 p/Share	1,000 Reduced 1.09%	90,864 ResMed Common Stock
Feb 10 2025	SELL Open market or private sale	$238,980 $238.98 p/Share	1,000 Reduced 1.08%	91,864 ResMed Common Stock
Jan 08 2025	SELL Open market or private sale	$234,040 $234.04 p/Share	1,000 Reduced 1.07%	92,864 ResMed Common Stock
Dec 09 2024	SELL Open market or private sale	$244,230 $244.23 p/Share	1,000 Reduced 1.05%	93,864 ResMed Common Stock
Nov 08 2024	SELL Open market or private sale	$249,000 $249.0 p/Share	1,000 Reduced 1.04%	94,864 ResMed Common Stock
Oct 08 2024	SELL Open market or private sale	$233,470 $233.47 p/Share	1,000 Reduced 1.03%	95,812 ResMed Common Stock
Sep 09 2024	SELL Open market or private sale	$246,420 $246.42 p/Share	1,000 Reduced 1.02%	96,812 ResMed Common Stock
Aug 15 2024	BUY Grant, award, or other acquisition	-	8,756 Added 8.22%	97,812 ResMed Common Stock
Aug 08 2024	SELL Open market or private sale	$212,160 $212.16 p/Share	1,000 Reduced 1.11%	89,056 ResMed Common Stock
Jul 08 2024	SELL Open market or private sale	$194,350 $194.35 p/Share	1,000 Reduced 1.1%	90,056 ResMed Common Stock
Jun 10 2024	SELL Open market or private sale	$209,810 $209.81 p/Share	1,000 Reduced 1.09%	91,056 ResMed Common Stock
May 08 2024	SELL Open market or private sale	$2,747,810 $211.37 p/Share	13,000 Reduced 12.37%	92,056 ResMed Common Stock
May 08 2024	BUY Exercise of conversion of derivative security	$1,219,680 $101.64 p/Share	12,000 Added 10.25%	105,056 ResMed Common Stock

Brett Sandercock

Chief Financial Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RSMDF shares.

Notify only if

Value

Insider Trading

Get notified when an Resmed Inc insider buys or sells RSMDF shares.

Notify only if

Operation

Value

Type

News

Receive news related to RESMED INC

Track Activities on RSMDF

Account